FDA Clearance Tracker · P980040-S124
TECNIS Synergy Intraocular Lens, TECNIS Synergy Toric II Intraocular Lens, TECNIS Synergy IOL with TECNIS Simplicity Del
Last checked: Nov 20, 2026Latest source record: Apr 28, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Apr 28, 2021
Approved
Time to decision
208 days
Received Oct 2, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P980040-S124
- Device name
- TECNIS Synergy Intraocular Lens, TECNIS Synergy Toric II Intraocular Lens, TECNIS Synergy IOL with TECNIS Simplicity Del
- Applicant location
- Irvine, CA
- Received
- Oct 2, 2020
- Decided
- Apr 28, 2021
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P980040
Device type
- Device type
- Lens, multifocal intraocular (MFK)
- Device class
- Class III
- Regulation
- 21 CFR 886.3600
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for TECNIS Synergy Intraocular Lens (Model ZFR00V), TECNIS Synergy Toric II Intraocular Lens (Models ZFW150, ZFW225, ZFW300, and ZFW375), TECNIS Synergy IOL with TECNIS Simplicity Delivery System (Model DFR00V), TECNIS Synergy Toric II IOL with TECNIS Simplicity Delivery System (Models DFW150, DFW225, DFW300 and DFW375).The TECNIS Synergy IOL, Model ZFR00V, is indicated for primary implantation for the visual correction of aphakia in adult patients, with less than 1 diopter of pre-existing corneal astigmatism, in whom a cataractous lens has been removed. Compared to an aspheric monofocal lens, the TECNIS Synergy IOL mitigates the effects of presbyopia by providing improved visual acuity at intermediate and near distances to reduce eyeglass wear, while maintaining comparable distance visual acuity. The lens is intended for capsular bag placement only.The TECNIS Synergy Toric II IOL, Models ZFW150, ZFW225, ZFW300, ZFW375, are indicated for primary implantation for the visual correction of aphakia and for the reduction of refractive astigmatism in adult patients with greater than or equal to 1 diopter of preoperative corneal astigmatism, in whom a cataractous lens has been removed. Compared to an aspheric monofocal lens, the TECNIS Synergy Toric II IOLs mitigate the effects of presbyopia by providing improved visual acuity at intermediate and near distances to reduce eyeglass wear, while maintaining comparable distance visual acuity. The lens is intended for capsular bag placement only.The TECNIS Simplicity Delivery System is used to fold and assist in inserting the TECNIS Synergy IOL which is indicated for primary implantation for the visual correction of aphakia in adult patients, with less than 1 diopter of pre-existing corneal astigmatism, in whom a cataractous lens has been removed. Compared to an aspheric monofocal lens, the TECNIS Synergy IOL mitigates the effects of presbyopia by providing improved visual acuity at intermediate and near distances to reduce eyeglass wear, while maintaining comparable distance visual acuity. The lens is intended for capsular bag placement only.The TECNIS Simplicity Delivery System is used to fold and assist in inserting the TECNIS Synergy Toric II IOLs that are indicated for primary implantation for the visual correction of aphakia and for reduction of refractive astigmatism in adult patients with greater than or equal to 1 diopter of preoperative corneal astigmatism, in whom a cataractous lens has been removed. Compared to an aspheric monofocal lens, the TECNIS Synergy Toric II IOLs mitigate the effects of presbyopia by providing improved visual acuity at intermediate and near distances to reduce eyeglass wear, while maintaining comparable distance visual acuity. The lens is intended for capsular bag placement only.
Source documents
Other decisions for Johnson & Johnson Surgical Vision, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- TECNIS PureSee IOL, Model DEN00V TECNIS PureSee Toric II IOLs, Model DET150, DET225, DET300, DET375PMA supplement
P980040-S176 · Decided Mar 11, 2026 · 223 days after receipt · Panel Track
Device type: intraocular lens (HQL) · Ophthalmology
K223566 · Decided Apr 14, 2023 · 136 days after receipt
Device type: Ophthalmic Femtosecond Laser (OOE) · Ophthalmology
K203060 · Decided Mar 12, 2021 · 155 days after receipt
Device type: Unit, Phacofragmentation (HQC) · Ophthalmology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.